Shingo Hatakeyama, MD

Dept. of Urology, Hirosaki University Graduate School of Medicine

Position Title: Associate professor
Department of Urology
Hirosaki University Graduate School of Medicine
5 Zaifu-chou, Hirosaki, Japan Phone: +81-172-39-5091
Fax: +81-172-39-5092

Employment
Hirosaki University School of Medicine, Department of Urology, Assistant Professor, May 2005 – present
Sanford Burnham Prebys Medical Discovery Institute, Research fellow, 2006-2008.
Akita City Hospital, Akita red cross hospital, Yuri Union hospital, Senboku Union hospital, Kyouritu Hospital, 2002-2005
Akita University School of Medicine, Department of Urology, Fellow, 2002–2005. Akita University School of Medicine, Department of Urology, Resident, 2000–2002.
Education
Ph.D. Urology, Akita University, Graduate School of Medicine, 2004
Dissertation: Hatakeyama S., Ohyama C., Minagawa S., Inoue T., Kakinuma H., Kyan A., Arai Y., Suga T., Nakayama J., Kato T., Habuchi T, and Michiko N. Fukuda. Functional Correlation of Trophinin Expression with the Malignancy of Testicular Germ Cell Tumor. Cancer Res. 2004 June. 64: 4257-4262.
Medical student, AKITA University School of Medicine, 1994-2000
Research area
Research interests: General urology, Urological surgery, Urothelial cancer, Prostate cancer, Renal cancer, kidney transplantation, Urological Oncology, urinary stone disease, end-stage renal disease, basic research, glycobiology

Disclosure information not submitted.

Presentation(s):

• MP15-10: Impact of disease status heterogeneity of the STAMPEDE trial arm J population on oncological outcomes in high-risk nonmetastatic prostate cancer

  Friday, May 13, 2022
  2:45 PM – 4:00 PM

• MP15-13: Outcomes comparison between the robot-assisted radical prostatectomy with extended pelvic lymph node dissection and neoadjuvant chemohormonal therapy without extended pelvic lymph node dissection in patients with organ confined high-risk prostate cancer

  Friday, May 13, 2022
  2:45 PM – 4:00 PM

• MP30-08: Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan

  Saturday, May 14, 2022
  1:00 PM – 2:15 PM

• PD35-11: The impact of older age on the oncological outcomes for high-risk metastatic hormone-sensitive prostate cancer treated with upfront intensive therapy

  Sunday, May 15, 2022
  8:40 AM – 8:50 AM